| Authors: |
González Trotter DE; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania dinko.gonzalez@regeneron.com., Meng X; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., McQuade P; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Rubins D; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Klimas M; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Zeng Z; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Connolly BM; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Miller PJ; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., O'Malley SS; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Lin SA; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Getty KL; Screening and Protein Sciences Department, Merck & Co., Inc., West Point, Pennsylvania., Fayadat-Dilman L; Biologics Discovery, Merck & Co., Inc., Palo Alto, California., Liang L; Biologics Discovery, Merck & Co., Inc., Palo Alto, California., Wahlberg E; Affibody AB, Solna, Sweden; and., Widmark O; Affibody AB, Solna, Sweden; and., Ekblad C; Affibody AB, Solna, Sweden; and., Frejd FY; Affibody AB, Solna, Sweden; and.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Hostetler ED; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania., Evelhoch JL; Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania. |
